PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33123895-7	2020	CD34+ AML stem/progenitor cells separated from 32 AML samples were treated with 4-HPR.	Fenretinide	80-85	CD34 molecule	Homo sapiens	0-4	
24021153-1	2014	AIMS: We have recently shown that fenretinide preferentially targets CD34(+) cells of acute myeloid leukemia (AML), and here, we test whether this agent exerts the effect on CD34(+) cells of chronic myeloid leukemia (CML), which are refractory to imatinib.	Fenretinide	34-45	CD34 molecule	Homo sapiens	69-73	
24021153-2	2014	RESULTS: As tested by colony-forming cell assays using clinical specimens, both number and size of total colonies derived from CD34(+) CML cells were significantly reduced by fenretinide, and by combining fenretinide with imatinib.	Fenretinide	175-186	CD34 molecule	Homo sapiens	127-131	
24021153-2	2014	RESULTS: As tested by colony-forming cell assays using clinical specimens, both number and size of total colonies derived from CD34(+) CML cells were significantly reduced by fenretinide, and by combining fenretinide with imatinib.	Fenretinide	205-216	CD34 molecule	Homo sapiens	127-131	
24021153-4	2014	Accordantly, fenretinide appeared to induce apoptosis in CD34(+) CML cells, particularly with regard to the cells in the subpopulation of CD34(+)CD38(-).	Fenretinide	13-24	CD34 molecule	Homo sapiens	57-61	
24021153-4	2014	Accordantly, fenretinide appeared to induce apoptosis in CD34(+) CML cells, particularly with regard to the cells in the subpopulation of CD34(+)CD38(-).	Fenretinide	13-24	CD34 molecule	Homo sapiens	138-142	
24021153-5	2014	Through cell quiescent assays, including Ki-67 negativity test, we added evidence that nonproliferative CD34(+) CML cells were largely eliminated by fenretinide.	Fenretinide	149-160	CD34 molecule	Homo sapiens	104-108	
24021153-7	2014	INNOVATION AND CONCLUSION: As compared with CD34(+) AML cells, the apoptotic effects of fenretinide on CD34(+) CML cells were more prominent whereas less varied among the samples of different patients, and also various stress-responsive events appeared to be more robust in fenretinide-treated CD34(+) CML cells.	Fenretinide	88-99	CD34 molecule	Homo sapiens	103-107	
24021153-7	2014	INNOVATION AND CONCLUSION: As compared with CD34(+) AML cells, the apoptotic effects of fenretinide on CD34(+) CML cells were more prominent whereas less varied among the samples of different patients, and also various stress-responsive events appeared to be more robust in fenretinide-treated CD34(+) CML cells.	Fenretinide	88-99	CD34 molecule	Homo sapiens	103-107	
23513221-4	2013	Fenretinide exerted a selective cytotoxic effect on primary AML CD34(+) cells, especially the LSC-enriched CD34(+)CD38(-) subpopulation, whereas no significant effect was observed on normal counterparts.	Fenretinide	0-11	CD34 molecule	Homo sapiens	64-68	
23513221-4	2013	Fenretinide exerted a selective cytotoxic effect on primary AML CD34(+) cells, especially the LSC-enriched CD34(+)CD38(-) subpopulation, whereas no significant effect was observed on normal counterparts.	Fenretinide	0-11	CD34 molecule	Homo sapiens	107-111	
23513221-5	2013	Methylcellulose colony formation assays further showed that fenretinide significantly suppressed the formation of colonies derived from AML CD34(+) cells but not those from normal CD34(+) cells.	Fenretinide	60-71	CD34 molecule	Homo sapiens	140-144